NEWS
Events
September 22, 2025
(title to be announced soon)
Research & Publications
September 22, 2025
Despite advances in hypertension treatment, nearly 75% of U.S. adults still struggle with uncontrolled blood pressure. A new nationwide analysis highlights the vast potential – and risks – of renal denervation (RDN) as a therapeutic option.
Best Practice
September 22, 2025
Renal denervation is gaining traction as a powerful tool in hypertension management—but it's not for everyone. Discover how ESC and ESH guidelines, clinical evidence, and practical tools like the Recor Medical selection form help identify the right candidates.
Events
September 22, 2025
Managing hypertension with renal denervation: all you need to know for your patients
Interview
September 22, 2025
A Joint Interview with Prof. Konstantinos Tsioufis (University of Athens, Hippocratio Hospital, Greece) and Prof. Sofie Brouwers (OLV Ziekenhuis Aalst, Belgium).
Did You Know?
September 22, 2025
A new clinical trial reveals that something as simple as arm position can skew blood pressure readings by up to 6.5 mm Hg — enough to misdiagnose hypertension or trigger unnecessary treatment. Find out what the study uncovered and why proper technique matters more than ever.
Press Releases
September 1, 2025
First Medical Device Approved in Japan for the Treatment of Hypertension.
Press Releases
September 1, 2025
Recor Medical and Otsuka Medical Devices welcome the recognition of renal denervation as a therapy option for resistant or uncontrolled hypertension in the 2025 AHA/ACC Guidelines.
Did You Know?
June 26, 2025
Back in March, we saw the publication of our second health economic analysis of the cost-effectiveness of Ultrasound Renal Denervation (uRDN) for the treatment of resistant hypertensive patients.
Research & Publications
June 26, 2025
Patients with uncontrolled high blood pressure saw meaningful reductions after switching to ultrasound renal denervation—even without increasing medications.
Best Practice
June 26, 2025
In this article, Professor Joachim Weil explores the pivotal role of patient empowerment in the context of renal denervation for treatment-resistant hypertension.
Interview
June 26, 2025
Prof. Roland Schmieder's study investigates the predictability of blood pressure reduction following renal denervation. The analysis shows a linear relationship between baseline blood pressure and the reduction: the higher the initial value, the greater the reduction.
Press Releases
May 16, 2025
World Hypertension Day’s Focus on High Blood Pressure Awareness, Management and Control Highlights Importance of New Therapies, like Ultrasound Renal Denervation.
Events
March 11, 2025
Advancing Hypertension Management: Renal Denervation in clinical practice
Events
March 11, 2025
Ultrasound Renal Denervation is now guideline-recommended: how do I get started?
Did You Know?
March 11, 2025
Sleep disorders, particularly sleep apnea, pose a significant yet often overlooked threat to cardiovascular health. One of the most concerning impacts is their connection to high blood pressure (hypertension).
Research & Publications
March 11, 2025
13 randomized sham-controlled trials (N=2,285) evaluated the efficacy and safety of ultrasound renal denervation (uRDN) and radiofrequency renal denervation (rRDN). uRDN demonstrated a greater reduction in ambulatory SBP across all time points.
Best Practice
March 11, 2025
For three years, Sergiu's life was dominated by extreme high blood pressure – an invisible yet life-threatening burden.
Interview
March 11, 2025
Dr. Karl-Philipp Rommel discusses the renal denervation (RDN) procedure as a treatment for patients with severe, uncontrolled hypertension. RDN is primarily considered for patients whose blood pressure remains high despite multiple medications.
Press Releases
September 3, 2024
The new ESC Guidelines for Management of Elevated Blood Pressure and Hypertension were presented at the ESC Congress in London and reinforce the safety and effectiveness of renal denervation, recommending its consideration as a treatment option to improve uncontrolled hypertension.
Press Releases
November 10, 2023
Innovative new treatment option for patients with uncontrolled hypertension now available in the United States
Press Releases
November 7, 2023
Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.
Press Releases
October 26, 2023
Analysis shows a maintained blood pressure lowering effect with fewer added medications following treatment with the Paradise™ Ultrasound Renal Denervation system
